Biotechnology MSD Secures Option on EVX-B3 Under the agreement, MSD will assume full responsibility and carry all costs for the further development of the EVX-B3 vaccine. The vaccine is designed to combat pathogens that cause opportunistic, recurrent infections, such as S. aureus, Enterococcus sp., and uropathogenic E. coli. So far, the companies have not disclosed further details, but the vaccine is reportedly […] Written by Thomas Gabrielczyk September 29, 2025September 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology Lilly’s oral SERD gets FDA nod in advanced breast cancer The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable type of hormone therapy. Written by Ben Fidler September 26, 2025September 26, 2025 Saving Bookmark this article Bookmarked
Biotechnology “‘Youth Molecule’ Shows Promise in Enhancing Quality of Life for In a groundbreaking expert consensus published in Nature Aging, a collective of over 25 internationally renowned scientists and clinicians have shed new light on the pivotal role of nicotinamide adenine dinucleotide (NAD⁺) in aging biology and metabolic health. This comprehensive review comes as the scientific community intensifies efforts to decipher how modulation of NAD⁺ metabolism […] Written by Bioengineer September 22, 2025September 22, 2025 Saving Bookmark this article Bookmarked
Biotechnology Why 1000 companies from more than 40 countries will gather in Barcelona this year Welcome to the official Labiotech.eu podcast – Beyond Biotech! Each week, we talk about what’s happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. […] Written by Dylan Kissane September 19, 2025September 19, 2025 Saving Bookmark this article Bookmarked
Biotechnology Flagship's Lila Sciences lands $235M to expand AI-powered autonomous research labs Flagship Pioneering’s Lila Sciences has landed a substantial $235 million series A as it looks to exceed the current limits of the drug discovery process through automation. Written by Admin September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
Biotechnology A Universal Solution Emerges: Anti-Linker Antibodies Simplify CAR-T Detection and Development The study reported significantly prolonged progression-free survival and a 44% improvement in overall survival. Recently, CAR-T has also shown great potential in treating autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis. However, CAR-T development has long faced a persistent challenge: each new CAR targeting a novel tumor antigen requires the iterative development of a fully validated […] Written by a.macht September 12, 2025September 12, 2025 Saving Bookmark this article Bookmarked
Biotechnology BioNTech says dual-acting lung cancer drug helped shrink tumors The Bristol Myers-partnered bispecific antibody kept small cell lung cancer under control in participants enrolled in a Phase 2 trial. Written by Jonathan Gardner September 9, 2025September 9, 2025 Saving Bookmark this article Bookmarked
Biotechnology Nursing Students’ Unique Professional Identities Explored In a groundbreaking study, researchers investigated the professional identity personas of male undergraduate nursing students, aiming to reveal the intricacies of their educational experiences and how they align or diverge from traditional gender norms in nursing. This research highlights an often overlooked aspect of nursing education: the unique challenges and opportunities faced by male students […] Written by Bioengineer September 6, 2025September 6, 2025 Saving Bookmark this article Bookmarked
Biotechnology The biggest biotech funding rounds in August 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields The companies Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds […] Written by Willow Shah-Neville September 2, 2025September 2, 2025 Saving Bookmark this article Bookmarked
Biotechnology Zydus' phase 3 liver disease win tees up filing to challenge Gilead and Ipsen Zydus Therapeutics has racked up a phase 2b/3 win in primary biliary cholangitis, clearing the path to a filing to establish the company as a challenger to Gilead, Intercept Pharmaceuticals and Ipsen. Written by Admin August 30, 2025August 30, 2025 Saving Bookmark this article Bookmarked
New Arabidopsis BIK1 Alleles Confirm Immunity Role In a groundbreaking study poised to redefine our understanding of plant immunity, researchers have unveiled novel insights into the pivotal roles of the receptor-like cytoplasmic kinases BIK1 and PBL1 in Arabidopsis. These kinases, previously studied primarily through single transfer DNA (T-DNA) insertional mutant alleles, are reaffirmed as central players in the plant’s pattern-triggered immunity (PTI) […] Written by Bioengineer January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Climate Action Costs More in the Global South. Here’s Why. – State of the Planet Clean energy technologies have become more affordable around the world. Yet for many countries in the Global South, the cost of transitioning to a low-carbon economy remains disproportionately high. But not because the equipment is more expensive: in fact, solar and wind components are often imported at comparable prices around the world, as global manufacturing scale and […] Written by Guest January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
New Arabidopsis BIK1 Alleles Confirm Immunity Role In a groundbreaking study poised to redefine our understanding of plant immunity, researchers have unveiled novel insights into the pivotal roles of the receptor-like cytoplasmic kinases BIK1 and PBL1 in Arabidopsis. These kinases, previously studied primarily through single transfer DNA (T-DNA) insertional mutant alleles, are reaffirmed as central players in the plant’s pattern-triggered immunity (PTI) […] Written by Bioengineer January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Climate Action Costs More in the Global South. Here’s Why. – State of the Planet Clean energy technologies have become more affordable around the world. Yet for many countries in the Global South, the cost of transitioning to a low-carbon economy remains disproportionately high. But not because the equipment is more expensive: in fact, solar and wind components are often imported at comparable prices around the world, as global manufacturing scale and […] Written by Guest January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism REDWOOD CITY, Calif.–(BUSINESS WIRE)–Dec. 31, 2025– Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and… Written by Admin January 7, 2026January 7, 2026 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked